The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

[1]  F. Vollenweider,et al.  Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors , 2012, Biological Psychiatry.

[2]  Marie L. Smith,et al.  Rapid processing of emotional expressions without conscious awareness. , 2012, Cerebral cortex.

[3]  L. Mayes,et al.  Investigating the impact of parental status and depression symptoms on the early perceptual coding of infant faces: An event-related potential study , 2012, Social neuroscience.

[4]  Erich Seifritz,et al.  Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments , 2012, Neuropsychopharmacology.

[5]  M. Geyer,et al.  Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers , 2012, Neuropsychopharmacology.

[6]  Felix Hasler,et al.  Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies , 2011, Journal of psychopharmacology.

[7]  Karl J. Friston,et al.  Behavioral/systems/cognitive Effective Connectivity during Processing of Facial Affect: Evidence for Multiple Parallel Pathways , 2022 .

[8]  Tessa Marzi,et al.  “Wanted!” The effects of reward on face recognition: electrophysiological correlates , 2011, Cognitive, affective & behavioral neuroscience.

[9]  Jim Lagopoulos,et al.  Neural correlates of emotional face processing in bipolar disorder: an event-related potential study. , 2011, Journal of affective disorders.

[10]  Wioleta Walentowska,et al.  Attention modulates emotional expression processing. , 2011, Psychophysiology.

[11]  Robert T. Schultz,et al.  Bidirectional communication between amygdala and fusiform gyrus during facial recognition , 2011, NeuroImage.

[12]  Asaid Khateb,et al.  Early ERP Modulation for Task-Irrelevant Subliminal Faces , 2011, Front. Psychology.

[13]  Manfred Herrmann,et al.  Time course of implicit processing and explicit processing of emotional faces and emotional words , 2011, Biological Psychology.

[14]  E. Sokhadze,et al.  Event-related Potential Study of the Effects of Emotional Facial Expressions on Task Performance in Euthymic Bipolar Patients , 2011, Applied psychophysiology and biofeedback.

[15]  C. Grob,et al.  Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. , 2011, Archives of general psychiatry.

[16]  Rebecca Elliott,et al.  Affective Cognition and its Disruption in Mood Disorders , 2011, Neuropsychopharmacology.

[17]  M. Tamietto,et al.  Neural bases of the non-conscious perception of emotional signals , 2010, Nature Reviews Neuroscience.

[18]  G. Yovel,et al.  Event‐related potential and functional MRI measures of face‐selectivity are highly correlated: A simultaneous ERP‐fMRI investigation , 2010, Human brain mapping.

[19]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[20]  F. Vollenweider,et al.  Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV) , 2010, PloS one.

[21]  K. Phan,et al.  Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation , 2010, Journal of psychopharmacology.

[22]  D. Luckenbaugh,et al.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. , 2010, Archives of general psychiatry.

[23]  N. Jaworska,et al.  Electrocortical effects of acute tryptophan depletion on emotive facial processing in depression-prone individuals , 2010, European Neuropsychopharmacology.

[24]  J. Hopfinger,et al.  Event-related potentials reveal temporal staging of dynamic facial expression and gaze shift effects on attentional orienting , 2009, Social neuroscience.

[25]  K. Phan,et al.  Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study , 2009, Psychopharmacology.

[26]  S. Hofmann,et al.  Electrophysiological correlates of spatial orienting towards angry faces: A source localization study , 2008, Neuropsychologia.

[27]  Asaid Khateb,et al.  Electrophysiological evidence for early non-conscious processing of fearful facial expressions. , 2008, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[28]  Catherine J. Harmer,et al.  Serotonin and emotional processing: Does it help explain antidepressant drug action? , 2008, Neuropharmacology.

[29]  M. Corbetta,et al.  Top-Down Control of Human Visual Cortex by Frontal and Parietal Cortex in Anticipatory Visual Spatial Attention , 2008, The Journal of Neuroscience.

[30]  Bruno Rossion,et al.  Does physical interstimulus variance account for early electrophysiological face sensitive responses in the human brain? Ten lessons on the N170 , 2008, NeuroImage.

[31]  M. Balconi,et al.  Consciousness and arousal effects on emotional face processing as revealed by brain oscillations. A gamma band analysis. , 2008, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[32]  G. Pourtois,et al.  Distributed and interactive brain mechanisms during emotion face perception: Evidence from functional neuroimaging , 2007, Neuropsychologia.

[33]  Wolfram Boucsein,et al.  Modification of N170 by different emotional expression of schematic faces , 2007, Biological Psychology.

[34]  A. Ishai,et al.  Effective connectivity within the distributed cortical network for face perception. , 2007, Cerebral cortex.

[35]  Lucy S. Petro,et al.  Dynamics of Visual Information Integration in the Brain for Categorizing Facial Expressions , 2007, Current Biology.

[36]  Gabriel Curio,et al.  MEG/EEG sources of the 170-ms response to faces are co-localized in the fusiform gyrus , 2007, NeuroImage.

[37]  P. Cowen,et al.  A single dose of citalopram increases fear recognition in healthy subjects , 2007, Journal of psychopharmacology.

[38]  Alumit Ishai,et al.  Sex, beauty and the orbitofrontal cortex. , 2007, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[39]  Ines Jentzsch,et al.  Event related potentials and the perception of intensity in facial expressions , 2006, Neuropsychologia.

[40]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[41]  Luiz Pessoa,et al.  Target visibility and visual awareness modulate amygdala responses to fearful faces. , 2006, Cerebral cortex.

[42]  D. Amaral,et al.  Synaptic organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey , 2005, The Journal of comparative neurology.

[43]  Gilles Pourtois,et al.  Dynamics of emotional effects on spatial attention in the human visual cortex. , 2006, Progress in brain research.

[44]  Urs Maurer,et al.  The face-specific N170 component is modulated by emotional facial expression , 2007, Behavioral and Brain Functions.

[45]  David C. Burr,et al.  Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors , 2005, Journal of Cognitive Neuroscience.

[46]  Christian Büchel,et al.  The functional and temporal characteristics of top-down modulation in visual selection. , 2005, Cerebral cortex.

[47]  Rebecca Elliott,et al.  The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study , 2005, Neuropsychopharmacology.

[48]  Luiz Pessoa,et al.  Quantitative prediction of perceptual decisions during near-threshold fear detection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Robert T. Knight,et al.  Top-down Enhancement and Suppression of the Magnitude and Speed of Neural Activity , 2005, Journal of Cognitive Neuroscience.

[50]  D. Amaral,et al.  The organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey , 2005, The Journal of comparative neurology.

[51]  Pradeep J Nathan,et al.  Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans , 2004, NeuroImage.

[52]  P. Cowen,et al.  Increased Positive versus Negative Affective Perception and Memory in Healthy Volunteers following Selective Serotonin and Norepinephrine Reuptake Inhibition , 2022 .

[53]  D. Grandjean,et al.  Electrophysiological correlates of rapid spatial orienting towards fearful faces. , 2004, Cerebral cortex.

[54]  J. Stekelenburg,et al.  The neural correlates of perceiving human bodies: an ERP study on the body-inversion effect , 2004, Neuroreport.

[55]  Felix Hasler,et al.  Acute psychological and physiological effects of psilocybin in healthy humans : a double-blind , placebo-controlled dose – effect study , 2004 .

[56]  R. Dolan,et al.  Brain Responses to the Acquired Moral Status of Faces , 2004, Neuron.

[57]  Margot J. Taylor,et al.  N170 or N1? Spatiotemporal differences between object and face processing using ERPs. , 2004, Cerebral cortex.

[58]  Leanne M Williams,et al.  Mapping the time course of nonconscious and conscious perception of fear: An integration of central and peripheral measures , 2004, Human brain mapping.

[59]  Patrik Vuilleumier,et al.  Time course and specificity of event-related potentials to emotional expressions , 2004, Neuroreport.

[60]  P. Cowen,et al.  Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. , 2004, The American journal of psychiatry.

[61]  B. Brandner,et al.  Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers , 2004, Neuropsychopharmacology.

[62]  Bruno Rossion,et al.  Early lateralization and orientation tuning for face, word, and object processing in the visual cortex , 2003, NeuroImage.

[63]  Margot J. Taylor,et al.  Early processing of the six basic facial emotional expressions. , 2003, Brain research. Cognitive brain research.

[64]  D. Amaral,et al.  Topographic organization of projections from the amygdala to the visual cortex in the macaque monkey , 2003, Neuroscience.

[65]  Matthew P. G. Allin,et al.  Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study , 2003, Neuroreport.

[66]  Richard B. Silberstein,et al.  Preliminary Electrophysiological Evidence For Modulation of the Processing of Negative Affect by Serotonin , 2003 .

[67]  R. Adolphs.  Cognitive neuroscience: Cognitive neuroscience of human social behaviour , 2003, Nature Reviews Neuroscience.

[68]  P. Skudlarski,et al.  The role of the fusiform face area in social cognition: implications for the pathobiology of autism. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[69]  D. Perrett,et al.  Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers , 2003, Neuropsychopharmacology.

[70]  Pradeep J Nathan,et al.  Antidepressants and Emotional Processing , 2003, Neuropsychopharmacology.

[71]  H. Emrich,et al.  The pharmacology of psilocybin , 2002, Addiction biology.

[72]  F. Vollenweider,et al.  Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. , 2002, Journal of pharmaceutical and biomedical analysis.

[73]  M. Spitzer,et al.  Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans , 2002, Neuropsychobiology.

[74]  M. Eimer,et al.  An ERP study on the time course of emotional face processing , 2002, Neuroreport.

[75]  E. Bernat,et al.  Event-related brain potentials differentiate positive and negative mood adjectives during both supraliminal and subliminal visual processing. , 2001, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[76]  P Krolak-Salmon,et al.  Processing of facial emotional expression: spatio‐temporal data as assessed by scalp event‐related potentials , 2001, The European journal of neuroscience.

[77]  M. Bar,et al.  Cortical Mechanisms Specific to Explicit Visual Object Recognition , 2001, Neuron.

[78]  D. Nutt,et al.  Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders , 1999, European Neuropsychopharmacology.

[79]  Tamara Hershey,et al.  Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis , 1999, Neuropsychopharmacology.

[80]  Terrence J. Sejnowski,et al.  Independent Component Analysis Using an Extended Infomax Algorithm for Mixed Subgaussian and Supergaussian Sources , 1999, Neural Computation.

[81]  A Dittrich,et al.  The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans , 1998, Pharmacopsychiatry.

[82]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[83]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[84]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[85]  Hans-Ulrich Wittchen,et al.  DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft , 1997 .

[86]  E. Minder,et al.  Development of a Gas Chromatography‐Mass Spectrometry Method for Determination of Ketamine in Plasma and Its Application to Human Samples , 1995, Therapeutic drug monitoring.

[87]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[88]  Neil A. Macmillan,et al.  Detection Theory: A User's Guide , 1991 .

[89]  P. Ekman.  Pictures of Facial Affect , 1976 .

[90]  L. Ettre.  The development of gas chromatography , 1975 .

[91]  B. Pitt.  Psychopharmacology , 1968, Mental Health.